Poland· PL-100281711
Fluoxetine Vitabalans
A fluoxetine product containing fluoxetinum, registered in Poland by Vitabalans Oy. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fluoxetine is registered in 17 of 19 countries.
Countries holding a registration under ATC N06AB03 (fluoxetine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Fluoxetine · ATC N06AB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fluoxetine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.084 in United States to $1.04 in Switzerland — a ×12 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Fluoxetine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.04
- IT Italy$0.25
- ES Spain$0.10
- US United States$0.084 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Fluoxetinum
- Manufacturer
- Vitabalans Oy
- Country
- Poland (PL)
- ATC code
- N06AB03
- ATC class
- Fluoxetine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990989232
- gtin05909990989188
- gtin05909990989195
- gtin05909990989201
- gtin05909990989225
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
598 interactions on record for fluoxetine.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluoxetine · interactions on record
598 records
- 64 severe
- 287 moderate
- 4 minor
- 120 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
123 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluoxetine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFluoxetineAurobindo Pharma Limited
- CzechiaFLUOXETINE VITABALANSVitabalans OY, Hämeenlinna
- SwitzerlandFluoxetin axapharm
- SwedenFluoxetine Vitabalans 20 mg Filmdragerad tablettVitabalans Oy
- IcelandFluoxetine VitabalansVitabalans Oy
- FinlandFluoxetine VitabalansVitabalans Oy
- NorwayFluoxetine VitabalansVitabalans Oy
- United KingdomFelicium 20mg capsulesOpus Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Felicium, Fluctine
- Belgium · Fluoxetin Ab, Fluoxetine Eg
- Bulgaria · Бифлокс
- Cyprus · Afeksin, Fluoxetine Aurobindo
- Czechia · Deprex, Fluoxetin Pharmconsul
- Germany · Fluoxetin 1 A Pharma, Fluoxetin Abz
- Denmark · Fluoxetin ”mylan”, Fluoxetin Hexal
- Estonia · Fluoxetine Vitabalans, Flux
- Spain · Fluoxetina Almus, Fluoxetina Aurovitas
- Finland · Fluoxetine Vitabalans, Seromex
- France · Fluoxetine Accord, Fluoxetine Almus
- United Kingdom (Northern Ireland) · Fluoxetine, Fluoxetine Accord-Uk
- Greece · Dagrilan, Exostrept
- Croatia · Portal
- Hungary · Floxet, Fluoxetin Zentiva
- Ireland · Fluoxetine Activase Pharmaceuticals, Fluoxetine Brillpharma (Ireland)
- Iceland · Fluoxetin Viatris, Fluoxetin Wh
- Italy · Fluoxeren, Fluoxetina Accord
- Lithuania · Fluoxetine Vitabalans, Flux
- Luxembourg · Fluoxetin Ratiopharm, Fluoxetine Eg
- Latvia · Fluoxetine Vitabalans, Flux
- Malta · Fluoxetine Accord Healthcare, Fluoxetine Activase Pharmaceuticals
- Netherlands · Fluoxetine Amdipharm, Fluoxetine Aurobindo
- Norway · Fluoxetin Ratiopharm, Fluoxetin Sandoz
- Portugal · Digassim, Fluoxetina Alter
- Romania · Fluoxetină Arena, Fluoxin
- Sweden · Fluoxetin Orifarm, Fluoxetin Ratiopharm
- Slovenia · Fluoksetin Vitabalans, Fodiss
- Slovakia · Fluoxetine Vitabalans, Magrilan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/26dc4e33-a19a-41ee-988b-39edd0c248e9 GET /v1/drugs/26dc4e33-a19a-41ee-988b-39edd0c248e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909990989188 ¦ Rp ¦ 77657\n10 tabl.\n05909990989195 ¦ Rp ¦ 77659\n20 tabl.\n05909990989201 ¦ Rp ¦ 77660\n30 tabl.\n05909990989225 ¦ Rp ¦ 77661\n60 tabl.\n05909990989232 ¦ Rp ¦ 77662\n100 tabl.",
"substance": "Fluoxetini hydrochloridum 22.36 mg",
"common_name": "Fluoxetinum",
"pl_product_id": "100281711",
"pozwolenie_nr": "20324",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about fluoxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.